Finally, to verify which lymphocyte subpopulation contributed to the synergistic antitumor effect of targeting PD-1 and PCSK9 in CRC, anti-CD4, anti-CD8, anti-NK1.1, and anti-CSF1R antibody were applied to deplete the corresponding subset of immune cells, respectively. This evidence concerns the gene PCSK9 and colorectal carcinoma.